Berry Street Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Berry Street Capital Management's HZNP Position: Q3 2023 in Review

Berry Street Capital Management reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 55% in Q3 2023, selling an estimated $11.4M and leaving 87,500 shares worth $10.1M. The position accounts for 2.97% of the portfolio, ranked #10.

Berry Street Capital Management first reported a position in HZNP in Q4 2022 and has held it in 4 quarters since. The position peaked at $47.7M in Q1 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

• Berry Street Capital Management held 87,500 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $10.1M as of Q3 2023.
• Berry Street Capital Management sold 106,250 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $11.4M.
• Horizon Therapeutics Public Limited Company Ordinary Shares made up 2.97% of Berry Street Capital Management's portfolio in Q3 2023, its #10 holding.
• Berry Street Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and has held it in 4 quarters since.
• Berry Street Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $47.7M in Q1 2023.
• 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Berry Street Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.